Drugmaker May Have Concealed Info From Feds

Article

WASHINGTON, D.C. - When officials at Warner-Lambert Co. discovered they had a potentially life altering diabetes drug in production, they were thrilled. However, new documents show that research quickly showed the drug, Rezulin, caused liver damage.

Executives allegedly continued to promote the drug, which generated $2.1 billion in sales before being taken off the market three years after approval by officials at the Food and Drug Administration (FDA).

The drug was removed from store shelves because many liver-related deaths were linked to its use. New documents show Warner-Lambert executives may have known about this potentially lethal side effect from the beginning, but instead decided to conceal the information.

Pfizer Inc., which has since acquired Warner-Lambert, has turned information over to officials. More than 2,000 lawsuits have been filed for the 5,100 estimated Rezulin users.

Information from www.sfgate.com

Related Videos
Medical investigators going over data. (AdobeStock 589197902 by Wasan)
CDC logo is seen on a laptop. (Adobe Stock 428450603 by monticellllo)
Association for the Health Care Environment (Logo used with permission)
COVID-19 germs, fungi, bacteria objects. (Adobe Stock 584704860 by chawalit)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
mRNA technology  (Adobe Stock 485886181 by kaptn)
Ambassador Deborah Birx, MD
Woman lying in hospital bed (Adobe Stock, unknown)
Photo of a model operating room. (Photo courtesy of Indigo-Clean and Kenall Manufacturing)
Related Content